D

Active Director Director DIN 09438345
DIN 09438345 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Deepak

Data last updated:

Deepak is a Director at Nav Chetna Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Nav Chetna Pharmaceuticals Private Limited reported revenue of ₹1.2 Lakh (FY 2024).

DIN 09438345
Primary Designation Director
Industry Chemicals
First Appointment 16 Dec 2021
Oldest Company Age 4 yrs
Largest company Nav Chetna Pharmaceuticals Private Limited · ₹1.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Dec 20212021₹1.2 Lakh (FY 2024)Active

Board colleagues of Deepak

NameDINCompanyDesignation
Kashmiri Lal09438344Nav Chetna Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nav Chetna Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Deepak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepak

Deepak currently holds 1 directorship: Nav Chetna Pharmaceuticals Private Limited (Director, since 16 Dec 2021, revenue ₹1.2 Lakh (FY 2024)).

Deepak was first appointed on 16 Dec 2021 as Director at Nav Chetna Pharmaceuticals Private Limited.

The current boards of Deepak's companies include Kashmiri Lal (Nav Chetna Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available